Fundz

IVF startup GonGlobal raises $1.2M for needle-free fertility treatments backed by Innovation Victoria and RMIT University.

PRIVATESep 02, 2026

Amount Raised

A$1.2 Million

Round Type

Seed

AustraliaBiotechnologyHealth Care

Investors

RMIT UniversityInnovation Victoria

Description

GonGlobal, a biotech startup developing needle-free IVF treatments, has raised $1.2 million in new funding. The round was backed by Innovation Victoria via its University Innovation Platform, with RMIT University matching $500,000 and a private investor contributing $200,000. The funding will accelerate development of GonGlobal's Ovulair drug delivery system, an inhaled alternative to IVF injections designed to make fertility treatment less invasive and more precise. The company was founded by Ellen Gonda and her father Dr Igor Gonda, inspired by Ellen's personal experience with IVF.

Quick answer

GonGlobal raised A$1.2 Million in a Seed round, dated September 2, 2026. Investors: RMIT University and Innovation Victoria. GonGlobal is based in Australia.

How much did GonGlobal raise?
GonGlobal raised A$1.2 Million in a Seed round on September 2, 2026.
Who invested in GonGlobal?
RMIT University and Innovation Victoria are named as investors in this round.
What does GonGlobal do?
GonGlobal is a biotech startup developing needle-free IVF treatments through an inhaled drug delivery system called Ovulair.
Where is GonGlobal based and how big is it?
GonGlobal is based in Australia. Fundz records about 2 employees.
Who are the decision-makers at GonGlobal?
Fundz holds 1 contact at GonGlobal, including the Co-Founder. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as GonGlobal that raised within 45 days of this round, from Fundz verified event records.

  • Vitonnix raised an undisclosed amount (Seed) on October 17, 2026.
  • GenSight Biologics raised $1.1M (Post-IPO Equity) on October 16, 2026.
  • Microbiotica raised $48M (Series C) on October 16, 2026.
  • Unravel Health raised $3.3M (Seed) on October 16, 2026.
  • Estuary Biotherapeutics raised $93M (Series A) on October 16, 2026.
  • Bioliberty raised $3.3M (Series A) on October 16, 2026.

Who to call at GonGlobal, and when

A new round usually means GonGlobal is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day GonGlobal raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at GonGlobal, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at GonGlobal. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

GonGlobal

Location

Australia

About

GonGlobal is a biotech startup developing needle-free IVF treatments through an inhaled drug delivery system called Ovulair. The company aims to make fertility treatment less painful, more precise, and more accessible by replacing traditional injections with inhaled alternatives. Founded by Ellen Gonda and her father Dr Igor Gonda, the startup emerged from LaunchVic's JumpStart Studio program and collaborates with RMIT University's research team.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment GonGlobal raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsEllen, Co-FounderSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for GonGlobal's next move

See what Strategic adds

GonGlobal raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.